Sibylle Loibl
西比利·洛布尔
MD, PhD
Chief Executive Officer, German Breast Group; Professor of Oncology德国乳腺集团首席执行官；肿瘤学教授
👥Biography 个人简介
Sibylle Loibl, MD, PhD is CEO of the German Breast Group and a globally recognized authority on neoadjuvant breast cancer treatment. She has led numerous GBG platform trials—including GeparSepto, GeparNuevo, and OlympiA—that established nab-paclitaxel, durvalumab, and olaparib as key treatment components in early and advanced TNBC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Neoadjuvant Treatment Innovation
Led GeparSepto trial demonstrating nab-paclitaxel superiority over solvent-based paclitaxel in neoadjuvant TNBC, and GeparNuevo showing durvalumab addition improves pCR rates in early TNBC.
OlympiA Adjuvant Olaparib Trial
Co-led OlympiA phase III trial demonstrating olaparib adjuvant therapy significantly improves invasive disease-free survival in high-risk early-stage BRCA1/2-mutated HER2-negative breast cancer.
Representative Works 代表性著作
Olaparib as Adjuvant Treatment in Patients with High-Risk Early-Stage HER2-Negative Breast Cancer and a BRCA1/2 Mutation (OlympiA)
New England Journal of Medicine (2021)
Phase III trial establishing adjuvant olaparib as standard of care for high-risk BRCA1/2-mutated early breast cancer, with significant iDFS and OS benefit.
Durvalumab in Addition to an Anthracycline Taxane-Based Neoadjuvant Treatment in Early Triple-Negative Breast Cancer (GeparNuevo)
Annals of Oncology (2019)
Randomized trial showing durvalumab significantly improves pCR in early TNBC when added to standard neoadjuvant chemotherapy, supporting immunotherapy integration.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 西比利·洛布尔 的研究动态
Follow Sibylle Loibl's research updates
留下邮箱，当我们发布与 Sibylle Loibl（German Breast Group (GBG) / Goethe University Frankfurt）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment